vers la météo de la validation par utilisateur
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+--------------SUBJ:V_PASS-N--------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+--------------------------COMP:V-N(by)--------------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+--------------------------COMP:V-N(by)--------------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------COMP:N-N(of)-----------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------COMP:N-N(of)-----------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+--------------SUBJ:V_PASS-N--------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+-------COMP:N-N(of)-------+ +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ +MOD_A+ | +MOD_ATT:N+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V_PASS-N(by) (increase,T0901317)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+--------------SUBJ:V_PASS-N--------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+--------------------------COMP:V-N(by)--------------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +------------------------COMP:V-N(In)------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | | +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,__NODE__) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +--------------------COMP:V-N(In)-------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +MOD_ATT:+ | | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (decrease,__NODE__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,decrease) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +--------------------COMP:V-N(In)-------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | | +-MOD_ATT:N-ADJ+ | +MOD_A+ | +MOD_ATT:+ | | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (decrease,__NODE__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,decrease) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +------------------------COMP:V-N(In)------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +--------------SUBJ:V-N-------------+ | | | | +-------COMP:N-N(of)-------+ | | | | | | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,__NODE__) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +--------------------COMP:V-N(In)-------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +--------------SUBJ:V-N-------------+ | | | | +-------COMP:N-N(of)-------+ | | | | | | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +MOD_ATT:+ | | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (decrease,__NODE__) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,decrease) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------------SUBJ:V-N----------------------------------------+ | +-----------------------------------COMP:N-N(of)----------------------------------+ | | | +-------------------------------COMP:N-N(of)-------------------------------+ | | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,mRNA) COMP:N-N(of) (@card@,mRNA) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | +-----------------------------------COMP:N-N(of)----------------------------------+ | | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +--------------------------COMP:N-N(of)-------------------------+ | | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,mRNA) COMP:N-N(of) (hydroxycholesterol,mRNA) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | +--------------------------COMP:N-N(of)-------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,mRNA) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------------SUBJ:V-N----------------------------------------+ | +-------------------------------COMP:N-N(of)-------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (@card@,mRNA) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ +---------------------------COMP:N-N(of)---------------------------+ | | +------------------------COMP:N-N(of)-----------------------+ | | | +---MOD_ATT:N-ADJ--+---------------COMP:V-N(In)--------------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ +---------------------------COMP:N-N(of)---------------------------+ | | +------------------------COMP:N-N(of)-----------------------+ | | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+ | +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ +---------------------------COMP:N-N(of)---------------------------+ | | +------------------COMP:N-N(of)------------------+ | | | +---MOD_ATT:N-ADJ--+---------------COMP:V-N(In)--------------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ +-------------------------------COMP:N-N(of)-------------------------------+ | | +----------------------------COMP:N-N(of)---------------------------+ | | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+----COMP:N-N(of)---+ +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (cell,__NODE__) COMP:N-N(of) (@card@,__NODE__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ +-------------------------------COMP:N-N(of)-------------------------------+ | | +----------------------COMP:N-N(of)----------------------+ | | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+----COMP:N-N(of)---+ | +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (cell,__NODE__) COMP:N-N(of) (hydroxycholesterol,__NODE__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ +MOD_A+ | +MOD_ATT:N+ | +MOD_AT+ +COMP:V_PASS-+ | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V_PASS-N(by) (increase,T0901317)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +--------------SUBJ:V-N-------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +--------------SUBJ:V-N-------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+ +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---MOD_ATT:N-ADJ--+---------------COMP:V-N(In)--------------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+ +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+----COMP:N-N(of)---+ | +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+----COMP:N-N(of)---+ | +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+----COMP:N-N(of)---+ +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | +--------------------------------SUBJ:V-N--------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | +--------------SUBJ:V-N-------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,hydroxycholesterol) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +-------COMP:N-N(of)-------+ | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------------SUBJ:V-N----------------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +--------------SUBJ:V-N-------------+ | | | | +-------COMP:N-N(of)-------+ | | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,@card@) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +-----------------------------------SUBJ:V-N-----------------------------------+ | | +-----------------SUBJ:V-N----------------+ | | +-------COMP:N-N(of)-------+ | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+ +COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:V-N(In) (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+---------------------------------------------COMP:V-N(In)---------------------------------------------+ | +--------------------------------------------SUBJ:V-N--------------------------------------------+ | | +-----------------------------------SUBJ:V-N-----------------------------------+ | | | +-----------------SUBJ:V-N----------------+ | | | +--------------SUBJ:V-N-------------+ | | | | +-------COMP:N-N(of)-------+ | | | | | +---MOD_ATT:N-ADJ--+ +-MOD_ATT:N-ADJ+ | | | | | | +MOD_ATT:N+ | +MOD_AT+ | +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) COMP:V-N(In) (increase,HepG2) SUBJ:V-N (increase,cell) SUBJ:V-N (increase,hydroxycholesterol) SUBJ:V-N (increase,expression) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------OBJ:V-N-------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+--------COMP:N-N(by)-------+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+--------COMP:N-N(by)-------+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------------SUBJ:V-N--------------+ +-----------OBJ:V-N-----------+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------OBJ:V-N-------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------OBJ:V-N-----------+ | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ | +---------------SUBJ:V-N--------------+ +-----------OBJ:V-N-----------+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------OBJ:V-N-----------+ | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------------SUBJ:V-N--------------+ +-----------------OBJ:V-N-----------------+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+--------------------------COMP:V-N(by)--------------------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------OBJ:V-N-------+ | | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-------OBJ:V-N-------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+--------------------------COMP:V-N(by)--------------------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------OBJ:V-N-----------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+--------------------------COMP:V-N(by)--------------------------+ | | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+--------------------------COMP:V-N(by)--------------------------+ | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+----------------COMP:V-N(In)----------------+--------------------------COMP:V-N(by)--------------------------+ | +---------------SUBJ:V-N--------------+ +-----------OBJ:V-N-----------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,expression)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+--------------------------COMP:V-N(by)--------------------------+ | | +---------------SUBJ:V-N--------------+ +-----------------OBJ:V-N-----------------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+--------------------------COMP:V-N(by)--------------------------+ | | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+--------------------------COMP:V-N(by)--------------------------+ | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+--------------------------COMP:V-N(by)--------------------------+ | +---------------SUBJ:V-N--------------+ +-----------------OBJ:V-N-----------------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ | | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------COMP:N-N(of)-----------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------OBJ:V-N-------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V_PASS-N--------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | +------------------------COMP:N-N(of)-----------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-------OBJ:V-N-------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+--------------------------COMP:V-N(by)--------------------------+ | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,expression)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+-----------COMP:V-N(by)-----------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+-----------COMP:V-N(by)-----------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ | +-------OBJ:V-N-------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ | +-----------OBJ:V-N-----------+ | | | +---------------SUBJ:V-N--------------+ | | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +---------------------COMP:N-N(by)---------------------+ | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ | +-------OBJ:V-N-------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------SUBJ:V-N---------+ | +-----------OBJ:V-N-----------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ | +-----------OBJ:V-N-----------+ | | | +---------SUBJ:V-N---------+ | | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ | +-------OBJ:V-N-------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+--------------SUBJ:V_PASS-N--------------+ +--------------SUBJ:V-N-------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+--------------SUBJ:V_PASS-N--------------+ +--------------SUBJ:V-N-------------+ | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V-N-------------+ | | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V-N-------------+ | | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ | +-------OBJ:V-N-------+ | | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------SUBJ:V-N------------------------+ | | +------------------COMP:N-N(of)------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------COMP:V-N(In)-------------------+--------------------------COMP:V-N(by)--------------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------------SUBJ:V-N--------------+ | +-----------OBJ:V-N-----------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | +------------------------COMP:N-N(of)-----------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------SUBJ:V-N------------------------+ | | +------------------COMP:N-N(of)------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+--------------SUBJ:V_PASS-N--------------+ +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V-N-------------+ | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------SUBJ:V-N------------------------+ | | +------------------COMP:N-N(of)------------------+ | | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+-----------COMP:V-N(by)-----------+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------SUBJ:V-N------------------------+ | | +------------------COMP:N-N(of)------------------+ +-----------COMP:V-N(by)-----------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+COMP:V_PASS-+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------------SUBJ:V-N-----------------------------+ | +------------------------COMP:N-N(of)-----------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------COMP:N-N(of)-----------------------+ +-----------COMP:V-N(by)-----------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (@card@,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ +-----------COMP:V-N(by)-----------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | | +---------COMP:V-N(of)--------+ | | +---MOD_ATT:N-ADJ--+ | +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+ | +MOD_AT+SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) COMP:V-N(of) (increase,__SP__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------------COMP:V-N(In)--------------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+ +-----COMP:V-N(of)----+ +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,@card@) COMP:V-N(In) (increase,expression) COMP:V-N(of) (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | +---MOD_ATT:N-ADJ--+ +-----COMP:V-N(of)----+ +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +---SUBJ:V-N---+COMP:V-N(by)+ | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) COMP:V-N(of) (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+------------------------------------------COMP:V-N(In)------------------------------------------+ | +---------------------------------COMP:V-N(In)---------------------------------+ | | +---------------COMP:V-N(In)--------------+ | | | +-----COMP:V-N(of)----+ | | +---MOD_ATT:N-ADJ--+ | +---SUBJ:V-N---+ +MOD_A+ | | +MOD_ATT:N+ +MOD_ATT+ +SUBJ:V-N+ +COMP:V-N(by)+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) COMP:V-N(In) (increase,cell) COMP:V-N(In) (increase,hydroxycholesterol) COMP:V-N(In) (increase,expression) COMP:V-N(of) (increase,__NODE__) SUBJ:V-N (increase,mRNA) COMP:V-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ +COMP:V_PASS-+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA) COMP:V_PASS-N(by) (increase,T0901317)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+-----------COMP:V-N(by)-----------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+-----------COMP:V-N(by)-----------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:V-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +---------------------COMP:N-N(by)---------------------+ | +---------SUBJ:V-N---------+ | +-----------OBJ:V-N-----------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ | +-----------OBJ:V-N-----------+ | | +---------SUBJ:V-N---------+ | | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+--------------------------COMP:V-N(by)--------------------------+ | +--------------SUBJ:V_PASS-N--------------+ | | +--------------SUBJ:V-N-------------+ | | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:V-N(by) (decrease,T0901317) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+--------COMP:N-N(by)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ +--------COMP:N-N(by)-------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V-N-------------+ | | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +--------------SUBJ:V-N-------------+ | | +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+ | | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+--------COMP:N-N(by)-------+ | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | +------------------COMP:N-N(of)------------------+ | +--------COMP:N-N(by)-------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | +---------------------------COMP:N-N(of)---------------------------+ | | | +------------------------SUBJ:V-N------------------------+ | | +------------------COMP:N-N(of)------------------+ | +--------COMP:N-N(by)-------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:N-N(of) (cell,__SP__) COMP:N-N(of) (hydroxycholesterol,__SP__) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +--------------SUBJ:V_PASS-N--------------+ | +-------------------COMP:V-N(In)-------------------+ +--------------SUBJ:V-N-------------+ | | | +------------------SUBJ:V-N------------------+ +-------COMP:N-N(of)-------+ | | | | | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+ | | | | | | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,expression) SUBJ:V_PASS-N (increase,expression)
+----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+--------COMP:N-N(by)-------+ | +---------SUBJ:V-N---------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------------SUBJ:V-N-----------------------------+ +--------COMP:N-N(by)-------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,@card@) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+--------COMP:N-N(by)-------+ | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+----------------------------------COMP:V-N(In)----------------------------------+ | +---------------------------------SUBJ:V-N---------------------------------+ | | +------------------------SUBJ:V-N------------------------+ +--------COMP:N-N(by)-------+ | | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +-SUBJ:V_PASS-N+ | | | | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,HepG2) SUBJ:V-N (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-------COMP:N-N(of)-------+ | | +---------------SUBJ:V-N--------------+ | +-MOD_ATT:N-ADJ+-SUBJ:V_PASS-N+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ | +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) SUBJ:V_PASS-N (increase,mRNA)
+-------------------------------COMP:V-N(In)-------------------------------+ | +------------------------SUBJ:V-N------------------------+ | | +---MOD_ATT:N-ADJ--+------SUBJ:V-N-----+ +--------COMP:N-N(by)-------+ +MOD_A+ | | +MOD_ATT:N+COMP:N-N(of+ +OBJ:V-+-SUBJ:V_PASS-N+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) MOD_ATT:N-ADJ (expression,__NODE__) MOD_ATT:N-N (expression,decrease) COMP:N-N(of) (expression,__SP__) COMP:V-N(In) (__NODE__,cell) SUBJ:V-N (__NODE__,hydroxycholesterol) SUBJ:V-N (__NODE__,expression) OBJ:V-N (__NODE__,mRNA) COMP:N-N(by) (mRNA,T0901317) SUBJ:V_PASS-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +-----------COMP:N-N(by)-----------+ | +------------------SUBJ:V-N------------------+ +-------OBJ:V-N-------+ | | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-----------COMP:N-N(by)-----------+ +----------------COMP:V-N(In)----------------+ +-------OBJ:V-N-------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------COMP:N-N(by)-----------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------COMP:N-N(by)---------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +-----------COMP:N-N(by)-----------+ | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-----------COMP:N-N(by)-----------+ +----------------COMP:V-N(In)----------------+ +-------OBJ:V-N-------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------COMP:N-N(by)---------------+ | | +---------------SUBJ:V-N--------------+ +-----------OBJ:V-N-----------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +---------------COMP:N-N(by)---------------+ | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------COMP:N-N(by)---------------+ +----------------COMP:V-N(In)----------------+ +-----------OBJ:V-N-----------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------COMP:N-N(by)---------------+ | | +---------SUBJ:V-N---------+ +-----------OBJ:V-N-----------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+---------------COMP:N-N(by)---------------+ +----------------COMP:V-N(In)----------------+ +-----------OBJ:V-N-----------+ | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------------SUBJ:V-N--------------+ +-----------------OBJ:V-N-----------------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +---------------------COMP:N-N(by)---------------------+ | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +---------------------COMP:N-N(by)---------------------+ | | +---------SUBJ:V-N---------+ +-----------------OBJ:V-N-----------------+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ | | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ | +------------------SUBJ:V-N------------------+ +-----------COMP:N-N(by)-----------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------COMP:N-N(by)---------------+ | +------------------SUBJ:V-N------------------+ +-----------OBJ:V-N-----------+ | | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (__SP__,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,__SP__) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+-------------------COMP:V-N(In)-------------------+ +---------------------COMP:N-N(by)---------------------+ | +------------------SUBJ:V-N------------------+ +-----------------OBJ:V-N-----------------+ | | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | | | | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . COMP:V-N(In) (decrease,HepG2) SUBJ:V-N (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+----------------COMP:V-N(In)----------------+ +-----------COMP:N-N(by)-----------+ | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+-------OBJ:V-N-------+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(by) (__NODE__,T0901317) OBJ:V-N (increase,__NODE__) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ | +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+COMP:N-N(of+ +MOD_AT+SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__SP__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (mRNA,__NODE__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------SUBJ:V-N---------+ +----COMP:N-N(of)---+ | | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +---SUBJ:V-N---+ | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,hydroxycholesterol) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)
+---------------------COMP:N-N(by)---------------------+ +----------------COMP:V-N(In)----------------+ +-----------------OBJ:V-N-----------------+ | | +---------------SUBJ:V-N--------------+ +----COMP:N-N(of)---+ +---SUBJ:V-N---+ | +MOD_A+ | +SUBJ:V-N+-OBJ:V-N-+ +MOD_ATT+ +SUBJ:V-N+ | | | | | | | | | | | | | | In HepG2 cells , 25 hydroxycholesterol and __NODE__ decrease expression of __SP__ __NODE__ mRNA that is increased by T0901317 . MOD_ATT:N-N (cell,HepG2) COMP:V-N(In) (decrease,cell) SUBJ:V-N (decrease,@card@) SUBJ:V-N (decrease,__NODE__) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,__NODE__) COMP:N-N(by) (expression,T0901317) MOD_ATT:N-ADJ (__NODE__,__SP__) SUBJ:V-N (be,mRNA) OBJ:V-N (increase,expression) SUBJ:V-N (increase,mRNA)